Wei‐Chien Huang
Papers
2
Total Citations
172
H-Index
2
About
Dr. Wei-Chien Huang is a distinguished surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for urologic and colorectal cancers. His major contributions lie in the comparative effectiveness of robotic versus laparoscopic surgery, particularly for rectal cancer. In his highly cited 2014 meta-analysis of eight studies—garnering 166 citations—Dr. Huang demonstrated that robotic total mesorectal excision offers superior outcomes over laparoscopic approaches, including lower conversion rates and better preservation of urinary and sexual function. This work has helped shape clinical guidelines and surgical decision-making worldwide. More recently, Dr. Huang has pioneered the single-port extraperitoneal transvesical robot-assisted radical prostatectomy (SETvRARP) for prostate cancer. His 2023 two-center study on the first 72 patients, though early, showcases his commitment to reducing surgical trauma and improving recovery. By coupling the da Vinci Xi platform with a 4-channel single port, he is pushing the boundaries of what is possible in robotic urology. Dr. Huang’s research not only validates new techniques but also directly improves patient quality of life, making him a leading voice in the evolution of oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2